{
    "code": "20000020",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=20000020",
    "time": "2016-07-22 05:01:28",
    "許可證字號": "衛署罕藥輸字第000020號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/10",
    "發證日期": "101\/07\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA02000002001",
    "中文品名": "愛服妥錠 5 毫克",
    "英文品名": "Votubia 5 mg tablets",
    "適應症": "「結節性硬化症併有腎血管肌脂肪瘤之成年病患」且須符合以下條件：其腎血管肌脂肪瘤最長直徑需≧4cm，且曾有發生臨床上有意義之出血或確認病灶有血管瘤（aneurysm）直徑≧5mm者，無法以外科手術或動脈栓塞治療，或經動脈栓塞治療或外科手術後無效或復發者。\r\n\r\n治療患有結節性硬化症(TS: tuberous sclerosis)相關腦室管膜下巨細胞星狀細胞瘤(SEGA: subependymal giant cell astrocytoma)且須介入治療但不適合接受治療性外科切除手術的患者。",
    "劑型": "110錠劑",
    "包裝": "4-1000粒鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "EVEROLIMUS",
    "限制項目": [
        ""
    ],
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": {
        "製造廠名稱": "F430099000  NOVARTIS PHARMA STEIN AG",
        "製造廠廠址": "SCHAFFHAUSERSTRASSE, CH-4332 STEIN, SWITZERLAND",
        "製造廠公司地址": "",
        "製造廠國別": "SWITZERLAND",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F430088200  NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35, CH-4056 BASEL SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099400",
            "成分名稱": "EVEROLIMUS",
            "含量描述": "(RAD n BHT)",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "罕藥輸00020, 00021_Afinitor 愛服妥錠-TWI-211015-105-04-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=007&Type=9"
        },
        {
            "title": "愛服妥錠-TWI-160215-回一校-104-09-16(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=008&Type=9"
        },
        {
            "title": "癌伏妥中文仿單-102-08-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=006&Type=9"
        },
        {
            "title": "癌伏妥-英文版___20120813.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=005&Type=9"
        },
        {
            "title": "癌伏妥-中文版___20120813.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=004&Type=9"
        },
        {
            "title": "癌伏妥-中文版-回三校___20120815.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=003&Type=9"
        },
        {
            "title": "860472_U12_P6_FOIL___20120813.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=002&Type=9"
        },
        {
            "title": "2047106_U12_P4_FB___20120813.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=001&Type=9"
        },
        {
            "title": "Afinitor 5mg tablets_Package_20120813-104-12-11(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000020&Seq=002&Type=8"
        }
    ]
}